Evidence map

ArticleActa diabetologica2025

PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients.

Lai-Chu See et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39347851